+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 15Years - 24Years
All Genders
ID07434544

Cardiometabolic Impact of Non-Nutritive Sweeteners in Young Adults with Type 1 Diabetes Using Automated Insulin Delivery

Led by Medical College of Wisconsin · Updated on 2026-10-20

20

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of non-nutritive sweeteners NNS on blood vessel health in young people with type 1 diabetes T1D. Since T1D is an autoimmune condition requiring lifelong insulin use, those affected face a higher risk of cardiovascular disease. The study aims to understand how NNS, common in sugar-free foods and drinks, might impact heart and metabolic health in this group. Participants will consume a 12-ounce cherry-flavored sports drink containing NNS within 10 minutes. This project uses a new dietary assessment tool along with blood tests to measure NNS levels, allowing researchers to link NNS exposure with heart and metabolic health outcomes. The study lasts for two years and focuses on young adults aged 15 to 24 with T1D who use automated insulin delivery systems. During the study, participants will be monitored for changes in blood vessel function and stiffness. Researchers will also assess how chronic NNS intake affects cardiovascular and metabolic health and blood sugar control specific to T1D. Data collection includes blood tests and food frequency questionnaires. The study includes ongoing evaluations over two years to track these health measures and their relation to NNS exposure.

CONDITIONS

Brief Title

Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)

Research Team

S

Susanne M Cabrera, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here